スタートアップ、抗老化薬の組み合わせが有効と主張

generation lab, founded by irina conboy, claims its 1-generation treatment, a combination of two existing drugs, can stop the spread of aging in the body. the company says it has seen benefits in a small group of participants, including improved vision, increased energy, and better physical performance. however, the company's approach to evidence has raised several red flags, including a pay-to-play clinical trial model and involvement of alternative medicine practitioners. the trial, led by longevity doctors who practice alternative medicine, including matt cook, will involve participants paying for their enrollment. this has sparked concerns about the legitimacy of the trial and the treatment's effectiveness. the outcome of this trial could impact the development of anti-aging treatments and the people seeking them.